Phase 3 trials are ongoing, and without completed large-scale safety and efficacy data, the compound cannot be considered ready for routine clinical use
Clinical Evidence & Research Findings The published research behind AOD-9604 and Tesamorelin tells two very different stories: AOD-9604s early efficacy signal didnt hold up in its largest trial, while Tesamorelins did which is the central reason one reached FDA approval and the other didnt
This may be especially helpful during a cut phase, when you may be intentionally eating fewer carbohydrates than normal
Get personalized treatment duration recommendations based on your age, skin condition, and goals
Lets break it down: TRT can increase dopa
Many patients notice improvements in sleep and energy within the first few weeks, with continued benefits developing over several months